Company Filing History:
1 out of 168 
1 out of 149 
1 out of 591 
Years Active: 2009
Title: The Innovations of Robin Plevin: A Pioneer in Peptide Derivatives
Introduction
Robin Plevin, based in Strathclyde, GB, is an accomplished inventor known for his work in the field of peptide derivatives and their pharmaceutical applications. With a single patent to his name, Plevin has made significant contributions that address various therapeutic needs.
Latest Patents
Plevin's notable patent is titled "Par-2-activating peptide derivative and pharmaceutical composition using the same." This invention relates to a peptide derivative characterized by a specific general formula that includes elements such as aryl groups and amino acid sequences. The patented derivative is established as a potential prophylactic and therapeutic agent for a wide range of health issues, including disorders related to masticatory function, swallowing difficulties, and intra-oral cavity infections. Additionally, it addresses conditions like stomach ulcers and Sjogren's syndrome, showcasing Plevin's commitment to advancing health care solutions.
Career Highlights
Throughout his career, Plevin has worked with prestigious institutions such as the University of Edinburgh and the University of Strathclyde. His time at these universities has provided a strong foundation for his research and innovation focus, emphasizing the importance of interdisciplinary collaboration in advancing scientific knowledge.
Collaborations
Plevin has collaborated with notable colleagues, including Robert Ramage and Kevin Thomas Shaw, who share his dedication to research and development in the pharmaceutical sciences. These partnerships have enabled him to enrich his work and contribute to the wider scientific community effectively.
Conclusion
Robin Plevin's contributions to the field of peptide derivatives represent an important step in pharmaceutical innovation. His dedication to addressing complex health issues through scientific research highlights the critical role inventors play in improving health outcomes. As we look to the future, Plevin's work will undoubtedly continue to inspire advancements in therapeutic applications.